MyAverix Finance
NS · Healthcare
Gujarat Terce Laboratories Ltd (524314)
Pharmaceuticals & Biotechnology
Gujarat Terce Laboratories Ltd (524314) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $265.40M, P/E ratio is 12.54, net margin is 1.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 524314
Gujarat Terce Laboratories Ltd (524314) — FAQ
What is Gujarat Terce Laboratories Ltd's market cap?
Gujarat Terce Laboratories Ltd (524314) has a reported market cap of $265.40M (data as of 2026-07-10).
What is 524314's P/E ratio?
The price-to-earnings (P/E) ratio for Gujarat Terce Laboratories Ltd (524314) is 12.54 (data as of 2026-07-10).
Does Gujarat Terce Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Gujarat Terce Laboratories Ltd (524314). Check the MyAverix Finance app for the latest dividend data.
What sector is Gujarat Terce Laboratories Ltd in?
Gujarat Terce Laboratories Ltd (524314) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 524314 listed on?
524314 is listed on NS.
What is Gujarat Terce Laboratories Ltd's net margin?
Gujarat Terce Laboratories Ltd (524314) reports a net margin of 1.1% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.